Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-14-001299

Options or other derivatives

  • President and CEO acquired 47,134 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KIDRON NADAV · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-04-09 Grant or award : show line 1 in the form Stock Option (right to buy) +47,134 $12.45 2024-04-09 47,134 47,134 D
Loading xslF345X03/zk1414761.xml…